Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need. Our innovation engine starts with identifying multiple rare diseases that share a common biology and then discovering novel therapeutics that can treat these diseases with a single therapy. Star consists of a family of companies, each focusing on a specific area of novel biology and developing first-in-class antibody therapeutics. Electra Therapeutics, the first company within our portfolio to be unveiled, is developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. 

Westlake Village BioPartners

Cormorant Asset Management

Cowen Healthcare Investments

New Leaf Venture Partners

OrbiMed

RA Capital Management

Redmile Group

Star Therapeutics

Our CEO, Adam Rosenthal, shares the origin story and mission of Star Therapeutics. We look at the “the long tail of disease”, the thousands of rare diseases with inadequate treatment, and see limitless opportunities to make an impact.
#UniverseOfPossbilities

Star is applying expertise in rare diseases and antibody drug discovery to advance drug programs that target multiple diseases with a single therapy.
#UniverseOfPossibilities

Star Therapeutics emerges from stealth mode raising $100M in financing since inception to be an innovation engine for rare disease therapies.
#UniverseOfPossbilities

Introducing Star Therapeutics. Our sights are set on developing life-changing therapies for as many rare diseases as possible for the millions of patients globally.
#UniverseOfPossibilities

Star Therapeutics is a biopharmaceutical company focused on developing life-changing therapies for rare diseases. They aim to address the unmet need for treatments for the millions of patients suffering from rare conditions. Their portfolio includes first-in-class antibody therapeutics built on novel biology.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 12, 2024 12:52 PM	2e11b109
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:STAR-THERAPEUTICS

Star Therapeutics